Food Safety Incidents

Origin unknown has been detected in Supplement the food in g notes insufree.

Written by SGS Digicomply Editorial Team | Feb 27, 2026 11:00:00 PM

Food Safety Incident Report

On February 12, 2026, a food safety incident was reported involving a dietary supplement identified as "Supplement the food in g notes insufree." The origin of the issue has been traced back to Brazil, where the supplement was produced.

The Brazilian Health Regulatory Agency, known as ANVISA, has classified this incident under the category of control, indicating that there may be concerns regarding the safety and quality of the product. While specific hazard categories have not been detailed, the involvement of a regulatory agency suggests that there may be potential risks associated with the consumption of this dietary supplement.

Consumers are advised to exercise caution and refrain from using this product until further information is provided by health authorities. It is crucial for individuals to stay informed about food safety incidents, especially those involving dietary supplements, as these products can significantly impact health and well-being.

For those who may have purchased this supplement, it is recommended to check for any official recalls or advisories issued by health authorities. Additionally, individuals should consult with healthcare professionals if they have consumed the product and experience any adverse effects.

Maintaining awareness of food safety issues is essential for protecting public health and ensuring that dietary supplements meet safety standards.

  • Incident: Origin unknown has been detected in Supplement the food in g notes insufree.
  • Date: 2026-02-12
  • Product: Supplement the food in g notes insufree
  • Market: Available to SGS Digicomply users only. Explore the platform (for enterprises, no individual plans)
  • Origin of issue: Brazil
  • Hazard: Available to SGS Digicomply users only. Explore the platform (for enterprises, no individual plans)
  • Incident Category: Control
  • Source: Brazilian Health Regulatory Agency - ANVISA